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Background: The WHO guidelines were revised recently to identify patients with severe dengue (SD) early. We
proceeded to determine the usefulness of the warning signs in the new WHO guidelines in predicting SD and we
have also attempted to define other simple laboratory parameters that could be useful in predicting SD.
Methods: Clinical and laboratory parameters were recorded in 184 patients in 2011, with confirmed dengue viral
infections, admitted to a medical ward in two tertiary care hospitals in Colombo, Sri Lanka.
Results: We found that the presence of 5 or more dengue warning signs were significantly (p = 0.02) associated
with the development of SD (odds ratio 5.14, 95% CI = 1.312 to 20.16). The AST levels were significantly higher
(p = 0.0001) in patients with abdominal pain (mean 243.5, SD ± 200.7), when compared to those who did not have
abdominal pain (mean 148.5, SD ± 218.6). Lymphocyte counts <1,500 cells/mm3 were significantly (p = 0.005)
associated with SD (odds ratio 3.367, 95% CI 1.396 to 8.123). High AST levels were also significantly associated
(p < 0.0001) with SD (odds ratio 27.26, 95% CI 1.632 to 455.2). Platelet counts <20,000cells/mm3, were again
significantly associated (p < 0.001) with severe disease (odds ratio 1.632 to 455.2, 95% CI 3.089 to 14.71). The PCR
was positive in 26/84 of the patients and we found that the infecting serotype was DEN-1 in all 26 patients.
Conclusions: The presence of 5 or more warning signs appears to be a predictor of SD. Lymphocyte counts
<1,500 cells/mm3, platelet counts <20,000/mm3 and raised AST levels were associated with SD and could be used
to help identify patients who are likely to develop SD.
Keywords: Dengue virus infection, Shock, Warning signs, WHO guidelines, Laboratory parameters, Clinical featuresBackground
Dengue viral infections have become one of the most
important mosquito borne viral infections in the world
and is one of the major emerging infectious diseases. It
is estimated that 2.1 million cases of dengue haemor-
rhagic fever (DHF)/dengue shock syndrome (DSS) occur
every year resulting in 21,000 deaths [1]. Infection with
the dengue virus (DV), may manifest as asymptomatic
or a mild febrile illness, dengue fever (DF), dengue* Correspondence: gathsaurie.malavige@ndm.ox.ac.uk
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reproduction in any medium, provided the orhaemorrhagic fever (DHF) or dengue shock syndrome
(DSS) which can be fatal [2,3].
Sri Lanka has been affected by epidemics of DHF for
over 2 decades. Dengue viral infections have been en-
demic in Sri Lanka since the mid 1960s, which was
when the first cases of DF/DHF were reported [4,5]. Al-
though the Sri Lankan population had been exposed to
the virus for decades, severe forms of dengue infection
(DHF/DSS) were rare before 1989. The first large out-
break of DHF occurred in 1989 with 206 clinically diag-
nosed cases of dengue and 20 deaths (case fatality rate
9.8%) and in 1990, 1080 cases with 60 deaths. Since then
the number of cases of dengue have been rising each
year and in recent years dengue ranks highest in mortal-
ity in mosquito borne infection in Sri Lanka [6]. Sriral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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years 2009 and 2010 with 35000 cases in year 2009 with
246 deaths and 34105 cases and 229 deaths in the year
2010 [7]. Not only is the incidence of dengue infections
rising in Sri Lanka, but also the infection is spreading to
all parts of Sri Lanka.
Case fatalities due to dengue infection are around
1-5% depending on the country and epidemic [8]. Early
detection of shock and other complications and support-
ive therapy has been shown to reduce the morbidity and
mortality [8-10]. There was much criticism regarding
the WHO 1997 dengue classification guidelines, in par-
ticular that it underestimated many patients who devel-
oped shock and severe dengue [11,12]. In addition,
many pointed out the need to standardize the dengue
diagnostic criteria in order to implement better patient
management guidelines [13]. Therefore, following the
observations of a large multi-centre study, which was
conducted in South East Asia and Latin America, the
WHO revised their guidelines in 2009 [13]. Accordingly
the WHO changed their clinical classification of acute
dengue as probable dengue, dengue with warning signs
and severe dengue, which were thought to be more sim-
ple and easier to understand [8,14]. Furthermore, the
revised guidelines have been shown to be more sensitive
and specific in detecting patients with severe dengue
than the traditional guidelines [15]. The warning signs
were devised in order to help health care professionals to
decide who needs hospital admission and more intensive
monitoring during epidemics of dengue infection, with-
out the need for extensive laboratory investigations [14].
During dengue epidemics in Sri Lanka, very large
numbers of patients are admitted every day and due to
the scarcity of resources, close monitoring of all dengue
patients becomes impossible. Therefore, especially once
patients are admitted to hospital, triage of patients based
on the presence of certain warning signs would be cru-
cial to decide the patients who are more likely to de-
velop severe disease. Such warning signs should be able
to help the medical personnel to make decisions regard-
ing those who need more intensive care. Therefore, we
proceeded to determine the usefulness of the warning
signs in the new WHO guidelines in predicting severe
dengue and we have also attempted to define other
simple laboratory parameters that could be useful in pre-
dicting severe dengue. In this study, we have character-
ized the clinical and laboratory features in a large cohort
of adult dengue patients with acute infection.
Methods
Patients
184 adult patients with clinical features suggestive of
dengue infection who were admitted to a general medical
ward in two tertiary care hospitals in Colombo duringthe year 2011, were enrolled in the study following
informed written consent. The study was approved by
the Ethical Review Committee of the University of Sri
Jayawardanapura. Clinical features such the presence of
dengue warning signs, blood pressure, pulse rate and
volume, general status of the patient, presence of any
bleeding manifestations and presence of any possible
fluid accumulation in the pleural cavity and abdomen
were monitored several times a day from the time of
admission to hospital, until they were discharged. La-
boratory investigations such as the full blood count,
AST, ALT were done several times a day in all patients
until they were discharged from hospital. Serum electro-
lytes, coagulation profiles, chest radiography and ultra-
sound scans of the abdomen were only done in selected
patients who developed severe dengue due to resource
limitations. All patients included in our study had an in-
crease in their haematocrits (HCTs), which was defined
as a HCT increase of ≥20% from the baseline of patient
or population of the same age and thrombocytopenia
(100,000 cells/mm3 or less). These patients were classi-
fied as having dengue with warning signs (moderately se-
vere dengue) and severe dengue according to the 2009
WHO guidelines [8]. Based on the 2009 WHO diagnostic
criteria, shock was defined as lowering of pulse pressure
to 20 mmHg or less or the presence of signs of poor ca-
pillary perfusion (cold extremities, poor capillary refill or
a rapid pulse rate) [8]. Accordingly, 38 (20.6%) patients
were classified as having shock. 2 other patients who did
not have shock were classified as having severe disease as
their liver enzymes, alanine transaminase (ALT) levels and
aspartate transaminase (AST) levels, were >1000 IU. Ac-
cordingly, 40 patients were classified as having severe
dengue and 144 patients were classified has having den-
gue with warning signs (non severe dengue).
Serology
Acute dengue infection was confirmed by testing the
serum samples which were collected after day 6 of ill-
ness with a commercial capture-IgM and IgG enzyme-
linked immunosorbent assay (ELISA) (Panbio, Brisbane,
Australia). The ELISA was performed and the results
were interpreted according to the manufacturer’s instruc-
tions. This ELISA assay has been validated as both sensi-
tive and specific for primary and secondary dengue virus
infections [16,17]. The combined use of both IgM and
IgG been shown to have a sensitivity of 99% and a spe-
cificity of 96% to distinguish between primary and sec-
ondary dengue infections [17]. Patients who only had
dengue virus specific IgM were classified as having a
primary dengue (PD) infection while those who had a
positive result for both IgM and IgG were classified as
having a secondary dengue (SD infection) [8]. Accord-
ingly, 46 (25%) of the individuals were classified has
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patients to be having primary dengue or secondary den-
gue based on this test alone may not be sensitive.
Dengue virus specific RT-PCR
Dengue virus RNA was extracted from serum using
QIAmp viral RNA mini kit (Qiagen). RNA was reverse
transcribed and the PCR was performed by using primer
and conditions as previously described [18]. When de-
termining the serotype of the infecting DV, positive con-
trols for DEN-1, DEN-2, DEN-3 and DEN-4 were used
in all experiments.
Statistical analysis
Statistical analysis was performed using Graph pad
PRISM version 4. As the data were not normally distrib-
uted, differences in means were compared using the
Mann–Whitney U test (two tailed). Degree of associ-
ation between clinical parameters and disease severity
was expressed as the odds ratio (OR), which was
obtained from standard contingency table analysis by
Haldane’s modification of Woolf ’s method. The Fisher’s
exact test was used to determine the p value. Receiver-
operator characteristic (ROC) curves showing the area
under the curve (AUC) were generated to determine the
discriminatory performance of platelet counts, lympho-
cyte counts and liver transaminase levels.
Results
Clinical parameters associated with severe dengue
The mean age the study participants was 27.18 (SD ±
11.74, range 15 to 68 years. 58 (31.8%) complained of
abdominal pain and 31 (16.8%) had at least one bleeding
manifestation. Table 1, describes the presence of WHO
warning signs in patients with severe dengue and non
severe dengue. Based on the 1997 WHO classification
all our patients would have been classified as having
dengue haemorrhagic fever (DHF) because all of them
had thrombocytopenia (100,000 cells/mm3 or less)Table 1 Clinical and laboratory parameters in patients with s
signs who did not develop severe dengue
WHO warning sign Presence in patients wi
non severe dengue
N = 144 (%)
Abdominal pain 42 (29.6)
Vomiting 57 (39.6)
Clinical fluid accumulation 23 (15.9)
Mucosal bleeding 18 (12.5)
Lethargy/restlessness 1 (0.07)
Increase in HCT 144 (100)
Reduction in platelet counts <100,000cells/cm3 144 (100)and a rising HCT which was defined as a HCT increase
of ≥20% from the baseline of patient or population of the
same age [19]. Of the 31 patients who developed bleeding
manifestations in the absence of shock, 15 had petechie,
12 had ecchymosis, two had epistaxis, eight had per vagi-
nal bleeding in the absence of their monthly period, four
had haematemesis and three had melena. In the 2011
WHO guidelines, fever accompanied by a haemorrhagic
manifestation along with thrombocytopenia and haemo-
concentration is considered as diagnostic as DHF [3].
However, since this study was carried out in mid 2011,
the tourniquet test was not carried out on any patients
as it was not mentioned under warning signs in the
2009 WHO dengue guidelines [8].
Presence of dengue warning signs and severity of dengue
All patients with severe dengue and non severe dengue
had at least one dengue warning sign. Of the patients
with severe dengue, 5 (12.5%) had five dengue warning
signs, 4 (10%) had four dengue warning signs, 8 (20%)
had 3 dengue warning signs, 8 (20%) had two dengue
warning signs and 15 (37.5%) had at least one dengue
warning sign. Of the patients with non severe dengue, 4
(2.78%) had five dengue warning signs, 15 (10.4%) had
four dengue warning signs, 20 (13.9%) had three dengue
warning signs, 46 (31.9%) had two warning signs and 67
(45.2%) had only one dengue warning sign. The presence
of five or more dengue warning signs was significantly
(p = 0.02) associated with the development of severe
dengue (odds ratio 5.14, 95% CI = 1.312 to 20.16). The
presence of two warning signs or less was significantly
associated (p = 0.046) with a reduced risk of developing
severe dengue (odds ratio 0.45, 95% CI 0.2163 to
0.9401). Of the patients with severe dengue 23 (57.5%)
had only one to two warning signs. However, 113
(76.3%) of those with non severe dengue had only one to
two warning signs. Therefore, it appears that patients
with non severe dengue had fewer dengue warning signs
when compared to those with severe dengue.evere dengue and in those with dengue with warning
th Presence in patients with
severe dengue
Odds ratio and CI P value
N = 40 (%)
16 (40) 1.69 (0.7820 to 3.352) 0.24
20 (50) 1.526 (0.7547 to 3.087) 0.28
11 (27.5) 2.094 (0.9186 to 4.775) 0.10
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ence of clinical fluid accumulation, mucosal bleeding
were higher in patients with severe dengue. However, a
statistically significant increase in patients with severe
disease was not observed for any of the WHO warning
signs. Although the odds ratio was >1 for all of the
warning signs, they had a poor positive predictive value.
For instance, the positive predictive value for abdominal
pain was 40%, vomiting 50%, clinical fluid accumulation
27.5% and for mucosal bleeding 22.5%. However, the
AST levels were significantly higher (p = 0.0001) in
patients with abdominal pain (mean 243.5, SD ± 200.7),
when compared to those who did not have abdominal
pain (mean 148.5, SD ± 218.6). No significant difference
(p = 0.56) was seen for ALT levels in patients with ab-
dominal pain and those who did not have abdominal
pain.
Laboratory parameters associated with severe dengue
The laboratory parameters presented in the WHO warn-
ing signs are a rise in the HCT and a concurrent drop in
the platelet counts. However, the guidelines highlight
that full blood counts should be done at the first visit
and that progressive leucopenia and rapid decrease in
platelet counts usually precede plasma leakage [8]. Since
all our patients who had severe dengue and non severe
dengue had a rising HCT and falling platelet counts, we
proceeded to analyze the usefulness of other simple para-
meters in patients with severe dengue and those who did
not have severe dengue. The differences in laboratory
parameters in those with severe dengue and the other
patients are shown in Table 2. The platelet counts were
significantly lower (p = 0.002) in patients with severe
dengue, AST levels were significantly higher (p = 0.009).
The ALT levels were not significantly higher (p = 0.09) in
patients with severe disease. Although statistically not
significant, the total leucocyte counts and the lymphocyte
counts were lower in patients with severe disease when
compared to those who did not develop severe disease.
Since low platelet counts, high AST levels and low




Platelet counts 24653 (19508)
Total white cell counts 2854 (1437)
Total lymphocyte counts 1201 (853.0)
Total Neutrophil counts 1501 (1501)
Aspartate transaminase levels 409.7 (912.5)
Alanine transaminase levels 194.4 (239.2)dengue, we went on to analyze if any of these tests could
be used to predict the development of severe disease.
We found that lymphocyte counts <1,500 cells/mm3 was
significantly (p = 0.005) associated with severe clinical
disease (odds ratio 3.367, 95% CI 1.396 to 8.123 (Table 3).
The positive predictive value of a lymphocyte counts
<1,500 cells/mm3 was 82.5%, with a specificity of 89.5%
and a sensitivity of 28.2%. However, the lymphocyte
counts had poor discriminatory value in predicting se-
vere dengue as the AUC was 0.6 (95% CI 0.5071 to
0.6974). Although the total white cell count was lower in
patients with severe dengue this was not statistically sig-
nificant. There was no difference in the neutrophil
counts in patients with severe dengue and non severe
dengue (Table 2). Therefore, lymphopenia (lymphocyte
counts <1,500 cells/mm3) rather than leucopenia, could
be a more useful predictive factor of severe dengue.
Severe organ impairment (AST or ALT >1000) is one
of the criteria of severe dengue in the new WHO guide-
lines [8]. Therefore, we proceeded to determine the use-
fulness of liver enzymes in predicting those who are
likely to develop severe dengue. All patients with severe
dengue had high AST levels (>45 IU). High AST levels
were also significantly associated (p < 0.0001) with severe
disease (odds ratio 27.26, 95% CI 1.632 to 455.2)
(Table 3). The wide CI for the odds ratio could be due
to a small sample size (184 patients) and also possibly
because none of the patients with severe dengue had
AST levels <45 IU. The positive predictive value of a
high AST (>45 IU) was 100%, with a specificity of 100%
and a sensitivity of 27.6%. However, the AST levels did
not have a good discriminatory value is predicting those
with severe dengue as the AUC was 0.65 (95% CI 0.5486
to 0.7436).
Platelet counts <20,000 cells/mm3, was again signifi-
cantly associated (p < 0.001) with severe disease (odds
ratio 1.632 to 455.2, 95% CI 3.089 to 14.71) (Table 3).
Again, platelet counts alone did not appear to have a
good discriminatory value in predicting those with severe
dengue (AUC 0.66). However, the combination of the
presence of 4 or more dengue warning signs, platelete and those who did not develop severe dengue









Table 3 Association of laboratory parameters with severe dengue infection
Clinical feature Severe Dengue Non severe dengue infection Odds ratio and CI P value
N = 40 N = 144
Lymphocytes <1500 33 84 3.367 (1.396 to 8.123) 0.005
White cell count < 4000 33 105 2.389 (0.8688 to 6.567) 0.091
AST >45 IU 40 105 27.26 (1.632 to 455.2) <0.0001
AST > 90 IU 25 76 1.491 (0.7265 to 3.061) 0.29
AST >225 IU 14 30 2.046 (0.9528 to 4.394) 0.09
Platelet counts <50,000/mm 34 101 2.413 (0.9437 to 6.168) 0.069
Platelet counts <20,000/mm 21 20 6.742 (3.089 to 14.71) <0.0001
Jayaratne et al. BMC Research Notes 2012, 5:645 Page 5 of 8
http://www.biomedcentral.com/1756-0500/5/645counts <50,000 cells/mm3 and the presence of lympho-
cyte counts <1,500 cells/mm3, was significantly (p = 0.002)
associated with the development of severe dengue (odds
ratio 5.18, 95% CI 1.917 to 14.00). The reason we chose
platelet counts <50,000 cells/mm3 for the analysis of this
purpose was that by the time the platelet counts dropped
to <20,000 cells/mm3 in those with severe dengue, they
were already critically ill.
Virus serotypes isolated from our patients
It was possible to obtain a blood sample during the first
5 days in 84/184 of the individuals included in the study.
RNA was extracted from the serum of these patients
and RT-PCR for dengue was carried out. The PCR was
positive in 26/84 of the patients and we found that the
infecting serotype was DEN-1 in all 26 patients. The
positive controls for DEN-2, DEN-3 and DEN-4 worked
in all experiments.
Discussion
The WHO changed their dengue disease classification
and management guidelines in year 2009 in order to de-
velop criteria which could be used to clearly differentiate
severe dengue from non severe dengue. In fact the new
classification criteria were found to be far more sensitive
and specific in detection of patients with severe dengue,
when compared to the traditional criteria [15,20]. After
carrying out extensive multicentre studies, simple clin-
ical signs and symptoms, which would enable medical
personal to clearly distinguish between severe and non
severe forms of dengue were developed [14]. The object-
ive of the use of warning signs was to enable health care
professionals to decide who needs hospital admission
and more intensive monitoring during epidemics of den-
gue infection. Although these warning signs have im-
mensely helped to decide who needs hospital admission,
due to the large numbers of individuals affected during
an epidemic of dengue, massive numbers of patients are
admitted to our hospital every day. However, in resource
poor setting such as in Sri Lanka, intense monitoring of
all patients admitted to hospital with dengue infection isimpossible due to the large numbers. Therefore, we
attempted to define the usefulness of the new WHO
warning signs in predicting those who are likely to de-
velop severe dengue in adult patients admitted to hos-
pital with acute dengue infection.
We found that the presence of all the WHO warning
signs such as abdominal pain, vomiting, clinical fluid ac-
cumulation were higher in patients with severe dengue.
Both abdominal pain and persistent vomiting are consid-
ered as warning signs in the revised WHO disease classi-
fication. Many patients are known to present with
abdominal pain [21,22] and it has been shown to be
associated with severe dengue [23,24]. Some patients
have been shown to present with symptoms predomin-
antly related to gastrointestinal symptoms such as
vomiting, diarrhoea and abdominal pain, which were
associated with a poor outcome [22,24]. Importantly, we
found that the presence of abdominal pain was signifi-
cantly associated with raised AST levels. Therefore, the
presence of abdominal pain in a patient with dengue
appears to be associated with liver involvement. The
presence of five or more dengue warning signs was sig-
nificantly (p = 0.02) associated with the development of
severe dengue (odds ratio 5.14, 95% CI = 1.312 to 20.16).
Therefore, although all warning signs are important, we
found that the presence of five or more warning signs
should particularly alert the physician of a higher possi-
bility of severe dengue in such patients.
The 2009 WHO guidelines include a high or progres-
sively rising haematocrit concurrent with a rapidly de-
creasing platelet count as warning signs. Although the
guidelines do not highlight leucopenia are as warning
sign, it is mentioned that progressive leucopenia and
rapid decrease in platelet counts usually precede plasma
leakage, In addition to leucopenia, we found that
lymphocyte counts <1,500 cells/mm3, platelet counts
<20,000/mm3 and raised AST levels were associated
with severe dengue and have better positive predictive
values in predicting severe dengue when compared to
clinical parameters alone. Since no difference was
observed in the neutrophil counts in those with severe
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penia is contributing to severe dengue. However, none
of these laboratory parameters when used alone had a
good discriminatory value in predicting those with se-
vere dengue.
The warning signs in 2009 WHO guidelines do pro-
vide advantage in resource poor countries where it is
sometimes not feasible to carry out laboratory investiga-
tions and is extremely useful to decide who needs hos-
pital admission [25]. However, there has been some
criticism regarding the 2009 WHO dengue guidelines, as
some experts believe that it has actually increased the
number of hospital admissions and thus the work load.
There have been suggestions that laboratory parameters
such as plasma leakage detected by haemoconcentration
should be included as a major criterion [26]. Many have
suggested that more emphasis should be placed on
plasma leakage as the main underlying problem in se-
vere dengue [27]. During epidemics of dengue infection
large numbers of patients are admitted to hospital and it
is almost impossible to closely monitor all patients due
to scarcity of resources. Therefore, we feel that simple
laboratory tests such as full blood counts and AST levels
could help in determining those who are likely to de-
velop severe dengue so that clinicians can determine the
patients who are most likely to need closer monitoring
and more intensive treatment after admission to hospital.
Studies done in children with acute dengue also have
shown that leucopenia (<4000 cells/mm3) was associated
with the development of shock [28]. Both lymphocyte
counts and white cell counts have been shown to be sig-
nificantly lower in patients with acute dengue infection
who were hospitalized, when compared to those who
were cared for as out-patients [29]. We too found that
lymphocyte counts <1,500 cells/mm3 was significantly
(p = 0.005) associated with severe clinical diseases (odds
ratio 3.367, 95% CI 1.396 to 8.123). The positive pre-
dictive value of a lymphocyte counts <1,500 cells/mm3
was 82.5% in predicting severe dengue. Although reduc-
tion of platelet counts are mentioned as a warning
sign, we found that platelet counts were more strongly
associated with severe dengue when they reduced to
<20,000cells/mm3. However, none of the laboratory
parameters on their own had a good discriminatory value
in predicting severe dengue. Therefore, we assessed if a
combination of clinical and laboratory parameters could
be used to predict severe dengue. We found that the
combination of the presence of 4 or more dengue warning
signs, platelet counts <50,000 cells/mm3 and the pres-
ence of lymphocyte counts <1,500 cells/mm3, was signifi-
cantly (p = 0.002) associated with the development of
severe dengue (odds ratio 5.18, 95% CI 1.917 to 14.00).
Raised AST levels were detected in all patients with
severe dengue and AST levels were significantly higherin patients with severe dengue. Hepatic involvement and
dysfunction is a well recognized complication of dengue
[30,31]. Hepatic dysfunction also leads to deranged co-
agulation profiles, which could contribute to bleeding in
dengue infections [31,32] and is associated with a high
mortality [30,33,34]. In the 2009 WHO guidelines, se-
vere dengue is also classified by the presence of AST
values >1000 IU. Although very correctly AST levels are
not included as a warning sign in the 2009 guidelines as
it would be a waste of resources to carry out AST levels
in all patients with suspected dengue, we feel that once
patients are admitted to hospital, it would be a useful
test to determine those needing more intense monitor-
ing and indeed is recommended in the guidelines to
detect those with AST > 1000 IU. Potts et al. have
also highlighted the usefulness of inclusion of AST
values >50 IU along with leucocyte and platelet counts in
correctly classifying individuals who are likely to de-
velop severe dengue [35]. We too feel that it would
be useful to include both the AST levels (below
1000 IU) and lymphocyte counts <1,500 cells/mm3
in the warning signs as these are very simple labora-
tory tests to carry out and would help in patient tri-
age in resource-poor settings.
Dengue infection is caused by four dengue virus sero-
types (DEN1-4) which are closely related. Although all
four serotypes have been circulating in Sri Lanka, DEN-
2 and DEN-3 were the predominant serotypes isolated
from patients with acute infection until year 2009. These
2 serotypes were responsible for 86% of acute dengue
infections whereas DEN-1 serotype only accounted for
7% of infections [36]. However, a new strain of the
DEN-1 was identified in Sri Lanka for the first time in
year 2009, which coincided with the dengue epidemic in
year 2009. DEN-1 was the only virus serotype identified
among patients in our cohort, which probably indicates
that DEN-1 was the predominant circulating serotype dur-
ing this period. The introduction of a new DEN-1 virus
strain to Sri Lanka probably resulted in a shift in the pre-
dominant circulating virus serotype and thus caused a
massive dengue epidemic in non immune individuals.
Conclusion
In summary, we have attempted to determine clinical
and laboratory parameters that would help us to predict
severe dengue infections and the usefulness of some of
the warning signs included in the revised WHO clinical
disease severity classification. We found that the pres-
ence of all the WHO warning signs such as abdominal
pain, vomiting, clinical fluid accumulation were higher
in adult patients with severe dengue and are useful signs
and that the presence of 5 or more dengue warning
signs was significantly associated with the development
of severe dengue. We also found that lymphocyte
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and raised AST levels were associated with severe dengue.
However, as this study was restricted to hospitalized adult
patients with dengue infection, the predictive values and
usefulness of these clinical and laboratory parameters may
differ in children and also in adult patients with less severe
forms of dengue. Furthermore, although we present data
on a cohort of 184 individuals, it will be important to in-
crease patient numbers in future studies in order to strat-
ify groups and minimize confounding factors.
The predominant circulating DV serotype during the
year 2011 appears to be DEN-1, which was in contrast
to the pattern observed before year 2009. Therefore, the
shift in the predominant circulating DV serotype would
have resulted in the massive dengue epidemics that oc-
curred in Sri Lanka during years 2010 and 2011.
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